Researchers in the US have said that advances in therapeutics are outpacing the development of diagnostics to guide their use, due to policy gaps and payment barriers around the world. The team, from ...

A paper in JAMA Psychiatry says mental health providers should ask if patients are using artificial intelligence chatbots, ...

Replimune Group, Inc. stock drops after a second FDA rejection for RP1 melanoma; cash runway <12 months. Click for more on ...

A woman who had been sick for many years with three autoimmune conditions has experienced a remarkable recovery after being ...

The decision, which has been a flashpoint in an ongoing debate about regulatory flexibility, was made because Replimune ...

Adam Richardson talks to Sarah Finnan about masculinity, the housing crisis, representing his generation on screen, and the ...

Combining the industry’s most compact cyclotron with an upright positioning system creates a proton therapy system small enough to fit into a linac vault ...

New research by an interdisciplinary team in Lithuania has revealed a promising and unconventional approach to cartilage ...

People still cling to an old promise about family life. They say a baby will steady a troubled home, deepen love, and make adulthood complete. It is an attractive promise because parenthood can bring ...

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...

Certain psychosocial and pharmacologic therapies may help people with cannabis use disorder achieve abstinence and reduce cannabis use frequency, per a network meta-analysis.

Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.